About SiPore15™

SiPore15™ is a breakthrough medical device for the reduction of blood sugar, with a non-invasive mode of action: designed to act locally in the gut without being absorbed by the body, the device offers a superior safety profile.

SiPore15™ is Sigrid Therapeutics’ lead product candidate in clinical development, originating from research at Stockholm University and Uppsala University, Sweden.

Designed for a purpose

SiPore15™ has been developed with optimal safety in mind. The device is orally available as a tasteless and odourless white powder, consisting of precisely engineered micrometre-sized synthetic amorphous silicon dioxide particles with tailored nano-sized porosity. The particles work exclusively in the gut and are not absorbed by the body.